Your session is about to expire
← Back to Search
Mindfulness and Placebo for Pain (MAPP) Study (MAPP Trial)
N/A
Waitlist Available
Led By Chung Jung Mun, PhD
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
1. ≥18 years old;
2. ability to speak, write, and read in English;
Timeline
Screening 3 weeks
Treatment Varies
Follow Up enrollment to end of 3-month follow-up
Awards & highlights
No Placebo-Only Group
Summary
This study proposes a three-arm randomized-controlled trial (RCT) that evaluates the feasibility and acceptability of combining a mindfulness-based therapy (MBT) and open-label placebo (OLP) treatment for individuals with chronic pain. Individuals with chronic pain will be recruited to participate in an 8-week trial, with a subsequent 3-month post-treatment follow-up. Participants will be randomly assigned to one of the following three conditions: 1. Mindfulness-Based Stress Reduction (MBSR) 2. OLP treatment 3. combination of MBSR and OLP treatment
Eligible Conditions
- Chronic Pain
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ enrollment to end of 3-month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~enrollment to end of 3-month follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability - Appropriateness of Daily Diary Length and Frequency
Acceptability - Appropriateness of Intervention Length and Frequency
Acceptability - Appropriateness of Other Study Measures
+9 moreOther study objectives
Adverse Events
Anxiety
Conditioned Pain Modulation
+9 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: OLP-OnlyExperimental Treatment1 Intervention
This experimental arm receives the OLP treatment only.
Group II: MBSR-OnlyExperimental Treatment1 Intervention
This experimental arm receives the 8-week MBSR program only.
Group III: MBSR+OLPExperimental Treatment1 Intervention
This experimental arm receives the 8-week MBSR program AND the 8-week OLP treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness-Based Stress Reduction (MBSR)
2018
Completed Phase 2
~1450
Find a Location
Who is running the clinical trial?
Arizona State UniversityLead Sponsor
301 Previous Clinical Trials
108,005 Total Patients Enrolled
2 Trials studying Chronic Pain
4,061 Patients Enrolled for Chronic Pain
National Center for Complementary and Integrative Health (NCCIH)NIH
862 Previous Clinical Trials
674,056 Total Patients Enrolled
49 Trials studying Chronic Pain
20,394 Patients Enrolled for Chronic Pain
Chung Jung Mun, PhDPrincipal InvestigatorArizona State University